Tuhura Biosciences earnings were -$33.7M for the trailing 12 months ending Sep 30, 2025, with -99.8% growth year over year. The latest HURA earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$7.1M, down 25.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HURA reported annual earnings of -$22.6M, with -22.7% growth.
HURA past earnings growth
How has HURA's earnings growth performed historically?
What were Tuhura Biosciences's earnings last quarter?
On HURA's earnings call on Invalid Date, Tuhura Biosciences (NASDAQ: HURA) reported Q3 2025 earnings per share (EPS) of -$0.14, up 74.07% year over year. Total HURA earnings for the quarter were -$7.10 million. In the same quarter last year, Tuhura Biosciences's earnings per share (EPS) was -$0.54.
As of the last Tuhura Biosciences earnings report, Tuhura Biosciences is currently losing money. Tuhura Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$32.70 million, a 7.72% decrease year over year.
What was HURA's earnings growth in the past year?
As of Tuhura Biosciences's earnings date in Invalid Date, Tuhura Biosciences's earnings has grown -99.75% year over year. This is 160.4 percentage points lower than the US Biotechnology industry earnings growth rate of 60.65%. HURA earnings in the past year totalled -$33.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.